170 related articles for article (PubMed ID: 34011024)
1. Effect assessment of methotrexate in combination with other chemotherapeutic agents for osteosarcoma in children: A protocol for systematic review and meta-analysis.
Yan JP; Xiang RM
Medicine (Baltimore); 2021 May; 100(20):e25534. PubMed ID: 34011024
[TBL] [Abstract][Full Text] [Related]
2. Clinical therapeutic effects of combined methotrexate and other chemotherapeutic agents in treating children and young patients with osteosarcoma: A protocol for systematic review and meta-analysis.
Peng C; Ren Z; Zhu J; Zhang P; Cao S; Hao Y
Medicine (Baltimore); 2021 Apr; 100(17):e25564. PubMed ID: 33907104
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of methotrexate, doxorubicin, and cisplatin for osteosarcoma: Study protocol for a systematic review of randomized controlled trial.
Tang QX; Wang LC; Wang Y; Gao HD; Hou ZL
Medicine (Baltimore); 2019 Feb; 98(6):e14442. PubMed ID: 30732208
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis.
Zhang B; Zhang Y; Li R; Li J; Lu X; Zhang Y
J Orthop Surg Res; 2020 Feb; 15(1):51. PubMed ID: 32054494
[TBL] [Abstract][Full Text] [Related]
5. An update of Scandinavian studies of osteosarcoma.
Elomaa I
Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
[No Abstract] [Full Text] [Related]
6. Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials.
Wang X; Zheng H; Shou T; Tang C; Miao K; Wang P
J Orthop Surg Res; 2017 Mar; 12(1):52. PubMed ID: 28356114
[TBL] [Abstract][Full Text] [Related]
7. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
Yu W; Tang L; Lin F; Yao Y; Shen Z
Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
10. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Xu M; Xu S; Yu X
World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the efficacy and safety of first-line chemotherapeutic agents for osteosarcoma.
Li Z; Ma X; Wang Z; Dong S; Wang B
Adv Clin Exp Med; 2024 May; 33(5):445-454. PubMed ID: 37747442
[TBL] [Abstract][Full Text] [Related]
12. Analysis of chemotherapy dosage and dosage intensity and survival outcomes of high-grade osteosarcoma patients younger than 40 years.
Sun L; Li Y; Li H; Zhang J; Li B; Ye Z
Clin Ther; 2014 Apr; 36(4):567-78. PubMed ID: 24636527
[TBL] [Abstract][Full Text] [Related]
13. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Winkler K; Bielack SS; Delling G; Jürgens H; Kotz R; Salzer-Kuntschik M
Cancer Treat Res; 1993; 62():269-77. PubMed ID: 7682088
[TBL] [Abstract][Full Text] [Related]
14. Clinical assessment of prophylactic chemotherapy in treating with hydatidiform mole: A protocol for systematic review and meta-analysis.
Xu F; Zheng YL; Lu XY; Qiao HF; Wang Y
Medicine (Baltimore); 2021 Jun; 100(24):e26341. PubMed ID: 34128882
[TBL] [Abstract][Full Text] [Related]
15. Effect of downregulation of serum MMP-3 levels by traditional Chinese medicine ingredients combined with methotrexate on the progression of bone injury in patients with rheumatoid arthritis: A protocol for a systematic review and meta-analysis.
Sun Y; Huang Y; Chen T; Li X; Chen J; Wang Z; Lin K; Gao Y; He L
Medicine (Baltimore); 2020 Oct; 99(43):e22841. PubMed ID: 33120813
[TBL] [Abstract][Full Text] [Related]
16. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
[TBL] [Abstract][Full Text] [Related]
17. Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.
Abou Ali B; Salman M; Ghanem KM; Boulos F; Haidar R; Saghieh S; Akel S; Muwakkit SA; El-Solh H; Saab R; Tamim H; Abboud MR
J Glob Oncol; 2019 Apr; 5():1-8. PubMed ID: 30946633
[TBL] [Abstract][Full Text] [Related]
18. The European Osteosarcoma Intergroup (E.O.I.) studies 1980-1991.
Craft AW; Burgers JM
Cancer Treat Res; 1993; 62():279-86. PubMed ID: 8096743
[No Abstract] [Full Text] [Related]
19. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
Min D; Lin F; Shen Z; Zheng S; Tan L; Yu W; Yao Y
Asia Pac J Clin Oncol; 2013 Mar; 9(1):71-9. PubMed ID: 22897971
[TBL] [Abstract][Full Text] [Related]
20. Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.
Burgers JM
Cancer Treat Res; 1993; 62():173-5. PubMed ID: 8096730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
